Neuroya

BrainComputer Interface for Optimizing Diagnosis and Management of Common Neuropathologies

Health Tech & Life Sciences
Non Active, Dec 2020 ceased to operate
Pre-Seed Jerusalem Founded 2017
Total raised
$50K
Last: Pre-Seed 2019-01
Stage
Pre-Seed
Founded
2017
Headcount
6
HQ
Jerusalem
Sector
Health Tech & Life Sciences

About

Neuroya developed a braincomputer interface that translates observations and the current understanding of the nervous system to manipulate behavior-related neural processes and restore or enhance functions. The company's platform optimizes the diagnosis and management of common neuropathologies (e.g., attention deficit hyperactivity disorder, stroke, and autism). Based on continuous data collection, the algorithm suggests personalized treatments and analysis, including real-time representation of brain activity through smart devices and more.

Funding history · 1 round · $50K total

2019-01
Pre-Seed Undisclosed

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical DiagnosticsMedical DevicesDiagnostics Devices
Technologies
Artificial Intelligence
Target customers
Healthcare & Life SciencesHealthcareProvidersPatients
Business model
B2B

Tags

neurologydiagnosticsneurosciencepersonalizationalgorithmsmedical-devicesreal-timedigital-healthcareautismartificial-intelligenceadhd